Modulation of the immune response to vaccine antigens: University of Bergen, Norway, June 18 - 21, 1996
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Basel [u.a.]
Karger
1998
|
| Series: | Developments in biological standardization
92 |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | XII, 372 S. Ill., graph. Darst. |
| ISBN: | 3805566409 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011852331 | ||
| 003 | DE-604 | ||
| 005 | 20210702 | ||
| 007 | t | ||
| 008 | 980325s1998 ad|| |||| 10||| eng d | ||
| 016 | 7 | |a 953251373 |2 DE-101 | |
| 020 | |a 3805566409 |9 3-8055-6640-9 | ||
| 035 | |a (OCoLC)38738035 | ||
| 035 | |a (DE-599)BVBBV011852331 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-11 | ||
| 050 | 0 | |a QR189 | |
| 082 | 0 | |a 615.372 |2 21 | |
| 084 | |a WF 9900 |0 (DE-625)148479: |2 rvk | ||
| 084 | |a XD 3300 |0 (DE-625)152554:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Modulation of the immune response to vaccine antigens |b University of Bergen, Norway, June 18 - 21, 1996 |c vol. ed.: Fred Brown ... |
| 264 | 1 | |a Basel [u.a.] |b Karger |c 1998 | |
| 300 | |a XII, 372 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Developments in biological standardization |v 92 | |
| 650 | 2 | |a Gène réponse immunitaire - Congrès | |
| 650 | 2 | |a Modificateurs réponse biologique - Congrès | |
| 650 | 2 | |a Vaccins - Congrès | |
| 650 | 4 | |a Immune System |x physiology |v Congresses | |
| 650 | 4 | |a Immune response |x Regulation |v Congresses | |
| 650 | 4 | |a Immunity, Cellular |v Congresses | |
| 650 | 4 | |a Immunological adjuvants |v Congresses | |
| 650 | 4 | |a Vaccines |x Standards |v Congresses | |
| 650 | 4 | |a Vaccines |x immunology |v Congresses | |
| 650 | 0 | 7 | |a Immunmodulation |0 (DE-588)4315157-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antigen |0 (DE-588)4002272-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Adjuvans |0 (DE-588)4141430-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1996 |z Bergen Norwegen |2 gnd-content | |
| 689 | 0 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | 1 | |a Adjuvans |0 (DE-588)4141430-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 1 | 1 | |a Antigen |0 (DE-588)4002272-9 |D s |
| 689 | 1 | 2 | |a Immunmodulation |0 (DE-588)4315157-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Brown, Fred |d 1925-2004 |e Sonstige |0 (DE-588)171991923 |4 oth | |
| 830 | 0 | |a Developments in biological standardization |v 92 |w (DE-604)BV000000884 |9 92 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008005408&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008005408 | ||
Record in the Search Index
| _version_ | 1804126437491343360 |
|---|---|
| adam_text | Contents
Session I
Adjuvants for Vaccines: General Considerations 1
Chairpersons: P. L. Lambert and K. Mills
The Mode of Action of Immunological Adjuvants 3
A.C. Allison
Will Adjuvants be Needed for Vaccines of the Future? 13
R. Bomford
Adjuvants and Delivery Systems for Viral Vaccines Mechanisms and Potential 19
R. Jennings, J.R. Simms, A.W. Heath
Rapporteur s Summary 29
K. Mills
Session 11
New Adjuvants (1) 31
Chairpersons: R. Bomford and A.C. Allison
Iscom, a Delivery System for Parenteral and Mucosal Vaccination 33
B. Morein, M. Villacres Eriksson, K. Lbvgren Bengtsson
QS 21 and QS 7: Purified Saponin Adjuvants 41
C. Kensil, J. Y. Wu, C.A. Anderson, D.A. Wheeler, J. Amsden
Induction of Virus Specific Immunity by Iscoms 49
A.D.M.E. Osterhaus, G.F. Rimmelzwaan
Rapporteur s Summary 59
A.C. Allison
Session III
New Adjuvants (2) 61
Chairpersons: J. Holmgren and R.K. Gupta
Biodegradable Polymer Microspheres as Vaccine Adjuvants and Delivery Systems 63
R.K. Gupta, A. C. Chang, G.R. Siber
PCPP as a Parenteral Adjuvant for Diverse Antigens 79
L.G. Payne, G. Van Nest, G.L. Barchfeld, G.R. Siber, R.K. Gupta, S.A. Jenkins
Rapporteur s Summary 89
J. Holmgren, R.K. Gupta
Session IV
Mucosal Immunity 91
Chairpersons: P. Brandtzaeg and T. Lehner
Cellular and Molecular Mechanisms for Induction of Mucosal Immunity 93
P. Brandtzaeg, I.N. Farstad, G. Haraldsen, F.L. Jahnsen
Lipidation as a Novel Approach to Mucosal Immunization 109
J.P. Tarn, A.L. Mora, C. Rao
Systemic Immunization with Conserved Pilus Associated Adhesins Protects Against Mucosal
Infections 117
S. Palaszynski, J. Pinkner, S. Leath, P. Barren, C.G. Auguste, J. Burlein, S. Hultgren,
S. Langermann
Adjuvant Effect of Non Toxic Mutants of E. Coli Heat Labile Enterotoxin Following Intra
nasal, Oral and Intravaginal Immunization 123
M. T. De Magistris, M. Pizza, G. Douce, P. Ghiara, G. Dougan, R. Rappuoli
Towards a Nasal Vaccine Against Meningococcal Disease, and Prospects for its Use as a
Mucosal Adjuvant 127
B. Haneberg, R. Dalseg, F. Oftung, E. Wedege, E.A. Hoiby, l.L. Haugen, J. Hoist,
S.R. Andersen, A. Aase, L. Meyer Naess, T.E. Michaelsen, E. Namork, L.R. Haaheim
Rapporteurs Summary 135
P. Brandtzaeg, T. Lehner
Session V
New Approaches in Vaccine Design 137
Chairpersons: J. Mestecky and M. Liu
The Potential of Retro Inverso Peptides as Synthetic Vaccines 139
M.H.V. Van Regenmortel, G. Guichard, N. Benkirane, J.P. Briand, S. Muller, F. Brown
Protective Immunity to Intracellular Parasites A Focus for Vaccine Research and a Challenge
to Immunization Programmes 145
M. Harboe
Oral Delivery of Micro Encapsulated DNA Vaccines 149
D.H. Jones, J.C.S. Clegg, G.H. Farrar
Nucleic Acid Vaccines Against Hepatitis Viruses 157
C.R. Howard, L.Gray, F. D Mello, J. Christopher, J. Craske
Immune Responses Against Hepatitis C Virus Structural Proteins Following Genetic Immu¬
nisation 163
G. Inchauspe, M.E. Major, I. Nakano, L. Vivitski, M. Maisonnas, C. Trtpo
Induction of a TH1 Type Cellular Immune Response to the Human Immunodeficiency Type 1
Virus by in Vivo DNA Inoculation 169
/. Boyer, K. Ugen, B. Wang, M. Chattergoon, A. Tsai, M. Merva, D.B. Weiner
Rapporteur s Summary 175
M. Liu
Session VI
Cytokines as Immunomodulators 177
Chairpersons: P. Beverley and M. Harboe
The Effect of IL 12 Treatment on Vaccine Enhanced Illness During Infection with Respiratory
Syncytial Virus 179
P.J. Openshaw, T. Hussell
Rapporteur s Summary 187
P. Beverley
Session VII
Studies of T Cell and B Cell Responses 189
Chairpersons: J. L. Virelizier and S. Rowland Jones
Antigen Independent Activation of Resting T Cells in the Liver of Patients with Chronic
Hepatitis 191
5. Abrignani
A Novel Method for Enhancement of T Independent Responses 195
P. Dullforce, D. Sutton, A.W. Heath
Cytotoxic Activity Induced by Mycobacterium bovis BCG 199
M. Gheorghiu, M. Lagranderie, A.M. Balazuc, B. Gicquel
The Role of Cytotoxic T Cells in HIV Infection 209
S. Rowland Jones, T. Dong, P. Krausa, J. Sutton, H. Newell, K. Ariyoshi, F. Gotch,
S. Sabally, T. Corrah, J. Kimani, K. MacDonald, F Plummer, J. Ndinya Achola, H. Whittle,
A. McMichael
Rapporteur s Summary 215
J. L. Virelizier, S. Rowland Jones
Session VIII
Preclinical Evaluation and in Vivo Models of Immunity 217
Chairpersons: E Andre and M. Slaoui
Immunopotentiating Reconstituted Influenza Virosomes as a Novel Antigen Delivery System 219
57. Cryz Jr., R. Gluck
Protective Mucosal Immunity Elicited by Targeted Lymph Node Immunization with a Subunit
SIV Envelope and Core Vaccine in Macaques 225
T. Lehner, Y. Wang, M. Cranage, L.A. Bergmeier, E. Mitchell, L. Tao, G. Hall,
M. Dennis, N. Cook, I. Jones, C. Doyle
Rapporteur s Summary 237
/. Robertson
Session IX
Role of Adjuvants in Immunization Programmes and Regulatory Issues 239
Chairpersons: J. Donlon andJ. Lower
Adjuvants Perspectives 241
ER. Vogel
Rapporteur s Summary 249
J. Robertson
Session X
Poster Session 251
Prevention of Rotavirus Diarrhoea in Foals by Parenteral Vaccination of the Mares: Field Trial 253
M. Barrandeguy, V. Parreho, M. Lagos Mdrmol, F. Pont Lezica, C. Rivas, C. Valle,
F. Fernandez
Modulation of the Immune Response to Tetanus Toxoid by Polylactide Polyglycolide Micro
spheres 259
K.B. Walker, D.K. L. Xing, D. Sesardic, M.J. Corbel
Influence of Several Adjuvants on the Immune Response Against a Recombinant Meningo
coccal High Molecular Weight Antigen 269
S. Gonzalez, C. Nazdbal, L. Vina, E. Caballero
Development of an Animal Model to Assess the Immunogenicity of Single dose Tetanus and
Diphtheria Vaccines Based on Controlled Release from Biodegradable Polymer Microspheres 277
R.K. Gupta, P. Griffin Jr., R.. Rivera, G.R. Siber
Kinetics Localization and Characteristics of B and T Cell Responses to Iscoms Containing
Human Influenza Virus Glycoproteins 289
M. Johansson, K. Lovgren Bengtsson, A. Sjb lander, B. Morein
In Vitro Determination of Antigen Quality: Biosensor Analysis and Fluorescence Spectroscopy 295
G.F.A. Kersten, W. Jiskoot, T. Hazendonk, E.C. Beuvery
Immunity Provided by Haemorrhagic Septicaemia Subunit Vaccine in Ruminants 301
F.S. Maslog
Cellular Immune Responses of Cattle to Cowdria ruminantium 309
D.M. Mwangi, D.J. McKeever, S.M. Mahan
Salivary Immune Responses after Gingival Immunization with Tetravaccinal and Bivaccinal
Formulations of Inactivated Micro Organisms 317
P. Casetta, F. Negretti
Effect of Aluminium Hydroxide and Meningococcal Serogroup C Capsular Polysaccharide on
the Immunogenicity and Reactogenicity of a Group B Neisseria meningitidis Outer Membrane
Vesicle Vaccine 323
E. Rosenqvist, E.A. H0iby, G. Bjune, A. Aase, A. Halstensen, A.K. Lehmann, J. Paulssen,
J. Hoist, T.E. Michaelsen, H. N0kleby, L.O. Fr0holm, O. Class
Humoral Response to HSV 1 Subunit Vaccines A Statistical Analyses 335
J.R. Simms, A.W. Heath, V.J. Richardson, R. Jennings
Systemic Development of a Block Copolymer Adjuvant for Trivalent Influenza Virus Vaccine 341
C.W. Todd, E. Lee, M. Balusubramanian, H. Shah, W.G. Henk, L.E. Younger,
M.J. Newman
Ovalbumin Coupled Either with Murine Red Blood Cells or Liposome Induces IgG but not
IgE Antibody Production 353
T. Uchida, S. Naito, A. Horino, M. Taneichi, J. Mizuguchi, Y. Nakano, T. Oka,
K. Ookuma, K. Morokuma, S. Sakurai, K. Komuro
|
| any_adam_object | 1 |
| author_GND | (DE-588)171991923 |
| building | Verbundindex |
| bvnumber | BV011852331 |
| callnumber-first | Q - Science |
| callnumber-label | QR189 |
| callnumber-raw | QR189 |
| callnumber-search | QR189 |
| callnumber-sort | QR 3189 |
| callnumber-subject | QR - Microbiology |
| classification_rvk | WF 9900 XD 3300 |
| ctrlnum | (OCoLC)38738035 (DE-599)BVBBV011852331 |
| dewey-full | 615.372 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.372 |
| dewey-search | 615.372 |
| dewey-sort | 3615.372 |
| dewey-tens | 610 - Medicine and health |
| discipline | Biologie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02472nam a2200601 cb4500</leader><controlfield tag="001">BV011852331</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210702 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980325s1998 ad|| |||| 10||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">953251373</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805566409</subfield><subfield code="9">3-8055-6640-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)38738035</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011852331</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR189</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.372</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WF 9900</subfield><subfield code="0">(DE-625)148479:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Modulation of the immune response to vaccine antigens</subfield><subfield code="b">University of Bergen, Norway, June 18 - 21, 1996</subfield><subfield code="c">vol. ed.: Fred Brown ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 372 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in biological standardization</subfield><subfield code="v">92</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Gène réponse immunitaire - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Modificateurs réponse biologique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Vaccins - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune System</subfield><subfield code="x">physiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune response</subfield><subfield code="x">Regulation</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunity, Cellular</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunological adjuvants</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield><subfield code="x">Standards</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield><subfield code="x">immunology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunmodulation</subfield><subfield code="0">(DE-588)4315157-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antigen</subfield><subfield code="0">(DE-588)4002272-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Adjuvans</subfield><subfield code="0">(DE-588)4141430-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1996</subfield><subfield code="z">Bergen Norwegen</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Adjuvans</subfield><subfield code="0">(DE-588)4141430-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Antigen</subfield><subfield code="0">(DE-588)4002272-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Immunmodulation</subfield><subfield code="0">(DE-588)4315157-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brown, Fred</subfield><subfield code="d">1925-2004</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)171991923</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in biological standardization</subfield><subfield code="v">92</subfield><subfield code="w">(DE-604)BV000000884</subfield><subfield code="9">92</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008005408&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008005408</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1996 Bergen Norwegen gnd-content |
| genre_facet | Konferenzschrift 1996 Bergen Norwegen |
| id | DE-604.BV011852331 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:17:26Z |
| institution | BVB |
| isbn | 3805566409 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008005408 |
| oclc_num | 38738035 |
| open_access_boolean | |
| owner | DE-12 DE-11 |
| owner_facet | DE-12 DE-11 |
| physical | XII, 372 S. Ill., graph. Darst. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Karger |
| record_format | marc |
| series | Developments in biological standardization |
| series2 | Developments in biological standardization |
| spelling | Modulation of the immune response to vaccine antigens University of Bergen, Norway, June 18 - 21, 1996 vol. ed.: Fred Brown ... Basel [u.a.] Karger 1998 XII, 372 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Developments in biological standardization 92 Gène réponse immunitaire - Congrès Modificateurs réponse biologique - Congrès Vaccins - Congrès Immune System physiology Congresses Immune response Regulation Congresses Immunity, Cellular Congresses Immunological adjuvants Congresses Vaccines Standards Congresses Vaccines immunology Congresses Immunmodulation (DE-588)4315157-7 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf Antigen (DE-588)4002272-9 gnd rswk-swf Adjuvans (DE-588)4141430-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1996 Bergen Norwegen gnd-content Impfstoff (DE-588)4026655-2 s Adjuvans (DE-588)4141430-5 s DE-604 Antigen (DE-588)4002272-9 s Immunmodulation (DE-588)4315157-7 s Brown, Fred 1925-2004 Sonstige (DE-588)171991923 oth Developments in biological standardization 92 (DE-604)BV000000884 92 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008005408&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Modulation of the immune response to vaccine antigens University of Bergen, Norway, June 18 - 21, 1996 Developments in biological standardization Gène réponse immunitaire - Congrès Modificateurs réponse biologique - Congrès Vaccins - Congrès Immune System physiology Congresses Immune response Regulation Congresses Immunity, Cellular Congresses Immunological adjuvants Congresses Vaccines Standards Congresses Vaccines immunology Congresses Immunmodulation (DE-588)4315157-7 gnd Impfstoff (DE-588)4026655-2 gnd Antigen (DE-588)4002272-9 gnd Adjuvans (DE-588)4141430-5 gnd |
| subject_GND | (DE-588)4315157-7 (DE-588)4026655-2 (DE-588)4002272-9 (DE-588)4141430-5 (DE-588)1071861417 |
| title | Modulation of the immune response to vaccine antigens University of Bergen, Norway, June 18 - 21, 1996 |
| title_auth | Modulation of the immune response to vaccine antigens University of Bergen, Norway, June 18 - 21, 1996 |
| title_exact_search | Modulation of the immune response to vaccine antigens University of Bergen, Norway, June 18 - 21, 1996 |
| title_full | Modulation of the immune response to vaccine antigens University of Bergen, Norway, June 18 - 21, 1996 vol. ed.: Fred Brown ... |
| title_fullStr | Modulation of the immune response to vaccine antigens University of Bergen, Norway, June 18 - 21, 1996 vol. ed.: Fred Brown ... |
| title_full_unstemmed | Modulation of the immune response to vaccine antigens University of Bergen, Norway, June 18 - 21, 1996 vol. ed.: Fred Brown ... |
| title_short | Modulation of the immune response to vaccine antigens |
| title_sort | modulation of the immune response to vaccine antigens university of bergen norway june 18 21 1996 |
| title_sub | University of Bergen, Norway, June 18 - 21, 1996 |
| topic | Gène réponse immunitaire - Congrès Modificateurs réponse biologique - Congrès Vaccins - Congrès Immune System physiology Congresses Immune response Regulation Congresses Immunity, Cellular Congresses Immunological adjuvants Congresses Vaccines Standards Congresses Vaccines immunology Congresses Immunmodulation (DE-588)4315157-7 gnd Impfstoff (DE-588)4026655-2 gnd Antigen (DE-588)4002272-9 gnd Adjuvans (DE-588)4141430-5 gnd |
| topic_facet | Gène réponse immunitaire - Congrès Modificateurs réponse biologique - Congrès Vaccins - Congrès Immune System physiology Congresses Immune response Regulation Congresses Immunity, Cellular Congresses Immunological adjuvants Congresses Vaccines Standards Congresses Vaccines immunology Congresses Immunmodulation Impfstoff Antigen Adjuvans Konferenzschrift 1996 Bergen Norwegen |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008005408&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000000884 |
| work_keys_str_mv | AT brownfred modulationoftheimmuneresponsetovaccineantigensuniversityofbergennorwayjune18211996 |